Please login to the form below

Not currently logged in
Email:
Password:

Clinuvel Pharmaceuticals

This page shows the latest Clinuvel Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs lead CHMP recommendations

Orphan drugs lead CHMP recommendations

Clinuvel's Scenesse is first drug set for European approval to treat rare intolerance to sunlight. ... Scenesse (afamelanotide), developed by Australian company Clinuvel Pharmaceuticals, was one of two orphan medicines for rare diseases recommended in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics